Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin

Cell and Tissue Research

Volumn 312, Issue 3, 2003, Pages 353-359

  Mori, Shuji ^a   Shinohata, Ryoko ^a,b   Renbutsu, Makoto ^c   Takahashi, Hideo Kohka ^a   Fang, Yang Il ^d   Yamaoka, Kiyonori ^b   Okamoto, Motoi ^b   Yamamoto, Itaru ^c   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Heparin; Histidine rich glycoprotein; Pig; Smooth muscle cell; Zinc

Indexed keywords

GLYCOPROTEIN; HEPARIN; HISTIDINE RICH GLYCOPROTEIN; UNCLASSIFIED DRUG; ZINC ION;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL GROWTH; CULTURE MEDIUM; DOSE RESPONSE; GROWTH INHIBITION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; SERUM; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; CELL DIVISION; HEPARIN; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEINS; SWINE; TRANSFORMING GROWTH FACTOR BETA; ZINC;

ANIMALIA; BOS TAURUS; BOVINAE; SUS SCROFA;

EID: 0038235745     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-003-0737-x     Document Type: Article

References (49)

1. Au YP, Dobrowolska G, Morris DR, Clowes AW (1994) Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ Res 75:15-22
2. Borza DB, Morgan WT (1998) Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals. J Biol Chem 273:5493-5499
3. Borza DB, Tatum FM, Morgan WT (1996) Domain structure and conformation of histidine-proline-rich glycoprotein. Biochemistry 35:1925-1934
4. Brack MJ, Ray S, Chauhan A, Fox J, Hubner PJ, Schofield P, Harley A, Gershlick AH (1995) The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome. J Am Coll Cardiol 26:947-954
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Busch SJ, Martin GA, Barnhart RL, Mano M, Cardin AD, Jackson RL (1992) Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J Cell Biol 116:31-42
7. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsh J, Holder D, Finnie K, Marquis JF, Naqvi S, Cohen E (1996) Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 94:1553-1560
8. Castellot JJ Jr, Addonizio ML, Rosenberg R, Karnovsky MJ (1981) Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 90:372-379
9. Castellot JJ Jr, Favreau LV, Karnovsky MJ, Rosenberg RD (1982) Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin: possible role of a platelet endoglycosidase. J Biol Chem 257:11256-11260
10. Castellot JJ Jr, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ (1985) Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124:13-20
11. Castellot JJ Jr, Pukac LA, Caleb BL, Wright TC, Karnovsky MJ (1989) Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 109:3147-3155
12. Chamley-Campbell JH, Campbell GR, Ross R (1981) Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89:379-383
13. Clowes AW, Karnowsky MJ (1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626
14. Engesser L, Kluft C, Briet E, Brommer EJ (1987) Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia. Br J Haematol 67:355-358
15. Faxon DP, Spiro TE, Minor S, Cote G, Douglas J, Gottlieb R, Califf R, Dorosti K, Topol E, Gordon JB, Ohmen M, ERA investigators (1994) Low molecular weight heparin in prevention of restenosis after angioplasty. Results of enoxaparin restenosis (ERA) trial. Circulation 90:908-914
16. Floege J, Eng E, Young BA, Couser WG, Johnson RJ (1993) Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380
17. Fujiwara Y, Kaji T (1997) Zinc potentiates the stimulation by basic and acidic fibroblast growth factors on the proliferation of cultured vascular smooth muscle cells. Res Commun Mol Pathol Pharmacol 97:95-106
18. Groggel GC, Marinides GN, Hovingh P, Hammond E, Linker A (1990) Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259-F265
19. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ (1980) Inhibition of rat arterial smooth muscle cell proliferation by heparin. Circ Res 46:625-634
20. Hajjar DP, Boyd DB, Harpel PC, Nachman RL (1987) Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cells. J Exp Med 165:908-913
21. Henson MC, Shi W, Greene SJ, Reggio BC (1996) Effects of pregnant human, nonpregnant human, and fetal bovine sera on human chorionic gonadotropin, estradiol, and progesterone release by cultured human trophoblast cells. Endocrinology 137:2067-2074
22. Hoover RL, Rosenberg R, Hearing W, Karnovsky MJ (1980) Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res 47:578-583
23. Hulett MD, Parish CR (2000) Murine histidine-rich glycoprotein: cloning, characterization and cellular origin. Immunol Cell Biol 78:280-287
24. Kluszynski BA, KimC, Faulk WP (1997) Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein. J Biol Chem 272:13541-13547
25. Koide T, Odani S (1987) Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region. FEBS Lett 216:17-21
26. Koide T, Foster D, Yoshitake S, Davie EW (1986) Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry 25:2220-2225
27. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
28. Lerch PG, Nydegger UE, Kuyas C, Haeberli A (1988) Histidine-rich glycoprotein binding to activated human platelets. Br J Haematol 70:219-224
29. Leung LL (1986) Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 77:1305-1311
30. Leung LL (1993) Histidine-rich glycoprotein: an abundant plasma protein in search of a function. J Lab Clin Med 121:630-631
31. Leung LL, Nachman RL, Harpel PC (1984) Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest 73:5-12
32. Lijnen HR, Hoylaerts M, Collen D (1980) Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 255:10214-10222
33. Lijnen HR, Hoylaerts M, Collen D (1983) Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. J Biol Chem 258:3803-3808
34. Majesky MW, Schwartz SM, Clowes MM, Clowes AW (1987) Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 61:296-300
35. Morgan WT (1981) Interactions of the histidine-rich glycoprotein of serum with metals. Biochemistry 20:1054-1061
36. Morgan WT, Koskelo P, Koenig H, Conway TP (1978) Human histidine-rich glycoprotein. II. Serum levels in adults, pregnant women and neonates. Proc Soc Exp Biol Med 158:647-651
37. Mori S, Nishibori M, Yamaoka K, Okamoto, M (2000) One-step purification of rabbit histidine rich glycoprotein by dye-ligand affinity chromatography with metal ion requirement. Arch Biochem Biophys 383:191-196
38. Mori S, Takahashi HK, Yamaoka K, Okamoto M, Nishibori M (2003) High affinity binding of serum histidine rich glycoprotein to nickel-nitrilotriacetic acid: the application to micro-quantification. Life Sci 73:93-102
39. Orlandi A, Ropraz P, Gabbiani G (1994) Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res 214:528-536
40. Owens GK, Geisterfer AA, Yang YW, Komoriya A (1988) Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107:771-780
41. Pukac LA, Ottlinger ME, Karnovsky MJ (1992) Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 267:3707-3711
42. Refson JS, Schachter M, Patel MK, Chan P, Wolfe JH, Sever P (1995) Correlation of heparin binding with responsiveness in human vascular smooth muscle cells. Biochem Soc Trans 23:172S
43. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE (1989) Heparin prevents vascular smooth muscle cell progession through the G1 phase of the cell cycle. J Biol Chem 264:6990-6995
44. Tanguay J-F, Wilensky RL, Weismann NJ, Bartorelli AL, Mehran R, Williams DO, Bucher TA, Wu H, Popma JJ, Kaplan AV (1998) Clinical trials involving the use of heparin to modulate the response to vascular injury and to reduce the incidence of restenosis (Abstract). Circulation 98:4-5
45. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
46. Underwood PA, Mitchell SM (2000) Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin. Cardiovasc Res 47:749-758
47. Underwood PA, Mitchell SM, Whitelock JM (1998) Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum. J Vasc Res 35:449-460
48. Wright TC Jr, Johnstone TV, Castellot JJ Jr, Karnovsky MJ (1985) Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol 125:499-506
49. Wright TC Jr, Pukac LA, Castellot JJ Jr, Karnovsky MJ, Levine RA, Kim-Park HY, Campisi J (1989) Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA 86:3199-3203